110 related articles for article (PubMed ID: 23911532)
1. Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study.
Kämppä N; Mäkelä KM; Lyytikäinen LP; Peltonen N; Hautamäki J; Seppälä I; Mononen N; Goebeler S; Karhunen PJ; Hervonen A; Hurme M; Jylhä M; Lehtimäki T
Exp Gerontol; 2013 Nov; 48(11):1167-72. PubMed ID: 23911532
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
[TBL] [Abstract][Full Text] [Related]
3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
4. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
Seddon JM; George S; Rosner B; Rifai N
Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
[TBL] [Abstract][Full Text] [Related]
5. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study.
Jylhä M; Paavilainen P; Lehtimäki T; Goebeler S; Karhunen PJ; Hervonen A; Hurme M
J Gerontol A Biol Sci Med Sci; 2007 Sep; 62(9):1016-21. PubMed ID: 17895441
[TBL] [Abstract][Full Text] [Related]
7. Serum apoptosis markers in acute liver failure: a pilot study.
Rutherford AE; Hynan LS; Borges CB; Forcione DG; Blackard JT; Lin W; Gorman AR; Shaikh OS; Reuben A; Harrison E; Reddy KR; Le WM; Chung RT;
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1477-83. PubMed ID: 17967565
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
[TBL] [Abstract][Full Text] [Related]
9. Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.
Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
Hepatogastroenterology; 2008; 55(85):1400-3. PubMed ID: 18795698
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
11. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
12. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23, hepatocyte growth factor, interleukin-6, high-sensitivity C-reactive protein and soluble urokinase plasminogen activator receptor. Inflammation markers in chronic haemodialysis patients?
Almroth G; Lönn J; Uhlin F; Nayeri F; Brudin L; Andersson B; Hahn-Zoric M
Scand J Immunol; 2013 Sep; 78(3):285-90. PubMed ID: 23721058
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes.
Cardinal H; Brophy JM; Bogaty P; Joseph L; Hébert MJ; Boyer L; Madore F
Am J Cardiol; 2010 Mar; 105(6):797-803. PubMed ID: 20211322
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
16. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease.
Salas-Salvadó J; Garcia-Arellano A; Estruch R; Marquez-Sandoval F; Corella D; Fiol M; Gómez-Gracia E; Viñoles E; Arós F; Herrera C; Lahoz C; Lapetra J; Perona JS; Muñoz-Aguado D; Martínez-González MA; Ros E;
Eur J Clin Nutr; 2008 May; 62(5):651-9. PubMed ID: 17440519
[TBL] [Abstract][Full Text] [Related]
17. Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study.
Kunutsor SK; Bakker SJL; Dullaart RPF
J Atheroscler Thromb; 2017 Aug; 24(8):804-818. PubMed ID: 28202840
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
[TBL] [Abstract][Full Text] [Related]
19. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST.
Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Hérnandez G; Egido J;
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):168-74. PubMed ID: 17053166
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients.
Masse M; Hébert MJ; Troyanov S; Vigneault N; Sirois I; Madore F
Nephrol Dial Transplant; 2002 Mar; 17(3):485-91. PubMed ID: 11865097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
